# Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability

Source: https://welltoldgrants.com/grants/for-fd-20-013-development-of-methods-for-evaluating-the-impact-of/  
Official notice: https://www.grants.gov/search-results-detail/327602

> Food and Drug Administration offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses and individuals. It is no longer open on Grants.gov.

| Field | Value |
|---|---|
| Opportunity number | FOR-FD-20-013 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | not set |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Individuals
- For profit organizations other than small businesses
- Small businesses

## What the grant funds

The purpose of the research is to develop methods for evaluating the impact of small design differences in the user interface of generic drug-device combination products when compared to the user interface of the reference listed drug (RLD). The results obtained from this research will be used to gain a better understanding of the factors related to small design differences in the user interface that impact substitutability between generic and branded drug-device combination products in end-user groups.

## Questions people ask

### Is FOR-FD-20-013 still open?

No. It is no longer open on Grants.gov. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability?

Food and Drug Administration accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses and individuals.

### What is the deadline for Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability?

Closed. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.